[go: up one dir, main page]

ATE354370T1 - Inaktivierte immunogene bakterielle ganzzell- zusammensetzungen - Google Patents

Inaktivierte immunogene bakterielle ganzzell- zusammensetzungen

Info

Publication number
ATE354370T1
ATE354370T1 AT02763771T AT02763771T ATE354370T1 AT E354370 T1 ATE354370 T1 AT E354370T1 AT 02763771 T AT02763771 T AT 02763771T AT 02763771 T AT02763771 T AT 02763771T AT E354370 T1 ATE354370 T1 AT E354370T1
Authority
AT
Austria
Prior art keywords
incapacitated
whole cell
bacterial
bacterium
lys minus
Prior art date
Application number
AT02763771T
Other languages
English (en)
Inventor
Janakiraman Ramachandran
Sriram Padmanabhan
Bharathi Sriram
Original Assignee
Gangagen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gangagen Inc filed Critical Gangagen Inc
Application granted granted Critical
Publication of ATE354370T1 publication Critical patent/ATE354370T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT02763771T 2001-09-27 2002-09-27 Inaktivierte immunogene bakterielle ganzzell- zusammensetzungen ATE354370T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32579601P 2001-09-27 2001-09-27

Publications (1)

Publication Number Publication Date
ATE354370T1 true ATE354370T1 (de) 2007-03-15

Family

ID=23269486

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02763771T ATE354370T1 (de) 2001-09-27 2002-09-27 Inaktivierte immunogene bakterielle ganzzell- zusammensetzungen

Country Status (9)

Country Link
US (1) US6913753B2 (de)
EP (1) EP1438066B1 (de)
JP (2) JP4554206B2 (de)
AT (1) ATE354370T1 (de)
CA (1) CA2461710C (de)
DE (1) DE60218327T2 (de)
ES (1) ES2282460T3 (de)
MX (1) MXPA04002866A (de)
WO (1) WO2003026690A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020192676A1 (en) * 2001-06-18 2002-12-19 Madonna Angelo J. Method for determining if a type of bacteria is present in a mixture
JP4849772B2 (ja) * 2001-09-27 2012-01-11 ガンガゲン インコーポレーティッド 免疫原性が低いリシン欠損バクテリオファージ
ES2346424T3 (es) * 2002-04-12 2010-10-15 Colorado School Of Mines Procedimiento de deteccion de bajas concentraciones de una bacteria diana que utiliza fagos para infectar celulas bacterianas diana.
US20050129711A1 (en) 2002-11-14 2005-06-16 Janakiraman Ramachandran Incapacitated whole-cell immunogenic bacterial compositions produced by recombinant expression
US20110097702A1 (en) * 2005-03-31 2011-04-28 Voorhees Kent J Methods and compositions for in situ detection of microorganisms on a surface
US8092990B2 (en) * 2005-03-31 2012-01-10 Colorado School Of Mines Apparatus and method for detecting microscopic organisms using bacteriophage
DK2038432T3 (en) 2006-06-30 2017-04-03 Rosetta Genomics Ltd METHOD OF DETECTING AND QUANTIFYING A TARGET NUCLEIC ACID GENERATED BY RT-PCR BY MIRNA
AU2008265989B8 (en) * 2007-06-15 2012-01-12 Microphage Incorporated Method of detection of microorganisms with enhanced bacteriophage amplification
US8697434B2 (en) * 2008-01-11 2014-04-15 Colorado School Of Mines Detection of phage amplification by SERS nanoparticles
US9441204B2 (en) * 2008-04-03 2016-09-13 Colorado School Of Mines Compositions and methods for detecting Yersinia pestis bacteria
EP2697387B1 (de) 2011-04-12 2021-09-15 Bactoclear Holdings PTE. LTD. Chimäre antibakterielle polypeptide
GB201600075D0 (en) * 2016-01-03 2016-02-17 Glaxosmithkline Biolog Sa Immunogenci composition
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US6130082A (en) 1988-05-05 2000-10-10 American Cyanamid Company Recombinant flagellin vaccines
GB9726233D0 (en) * 1997-12-11 1998-02-11 Medeva Europ Ltd Vaccines containing attenuated bacteria
JP4849772B2 (ja) * 2001-09-27 2012-01-11 ガンガゲン インコーポレーティッド 免疫原性が低いリシン欠損バクテリオファージ

Also Published As

Publication number Publication date
CA2461710A1 (en) 2003-04-03
EP1438066A4 (de) 2005-10-12
JP4554206B2 (ja) 2010-09-29
EP1438066B1 (de) 2007-02-21
US20030152589A1 (en) 2003-08-14
WO2003026690A1 (en) 2003-04-03
ES2282460T3 (es) 2007-10-16
DE60218327T2 (de) 2007-10-31
EP1438066A1 (de) 2004-07-21
JP2005508912A (ja) 2005-04-07
US6913753B2 (en) 2005-07-05
MXPA04002866A (es) 2005-06-06
DE60218327D1 (de) 2007-04-05
JP2010180227A (ja) 2010-08-19
CA2461710C (en) 2013-01-15
WO2003026690A9 (en) 2004-09-16

Similar Documents

Publication Publication Date Title
ATE354370T1 (de) Inaktivierte immunogene bakterielle ganzzell- zusammensetzungen
NZ291262A (en) E. coli heat-labile enterotoxin derivatives and their use as oral adjuvants
BR0113822A (pt) Vacina
MXPA03008154A (es) Novedoso adyuvante de vacuna de proteosoma-liposacarido.
RU2008102654A (ru) Инактивированные химерные вакцины и связанные с ними способы применения
DE69838383D1 (de) Kulturmedium mit sojabohnenextrakt als aminosäuren-quelle und ohne proteinkomplexe tierischen ursprungs
HUP0000992A2 (hu) Sejttenyészetben szaporodni képes, géntechnológiailag módosított, fertőző nyálkatömlő-betegséget okozó vírus (IBDV) mutánsai
UA85371C2 (ru) Модифицированный вирус коровьей оспы ankara для вакцинации новорожденных
WO2003082183A3 (en) Protein-based streptococcus pneumoniae vaccines
DE602004028029D1 (en) Rwendung
SE9003198L (sv) Fiskvaccin omfattande en virulent, invasiv bakterie
ATE458496T1 (de) Hiv-vakzine und anwendungsverfahren
WO2002034773A3 (en) Streptococcal genes
ATE268384T1 (de) Analog von haemophilus hin47 mit verminderter protease aktivität
Tafuku et al. Japanese encephalitis virus structural and nonstructural proteins expressed in Escherichia coli induce protective immunity in mice
NO20013102D0 (no) Gener, proteiner og deres anvendelse
DK0573527T3 (da) Fremstilling og anvendelse af formalindræbte, kolonisationsfaktor-antigen(CFA)-udtrykkende E. coli-organismer til vaccinati
Fischer et al. Intranasal immunization of guinea pigs with an immunodominant foot-and-mouth disease virus peptide conjugate induces mucosal and humoral antibodies and protection against challenge
CN101559223B (zh) 流脑白百破联合疫苗
CY1107560T1 (el) Ζωντανα εξασθενημενα βακτηρια για χρηση σε εμβολιο
RU2004129738A (ru) Бактериальные споры
EE200200157A (et) Vaktsiin
HUP0101081A2 (hu) Tápközeg és eljárás vírustenyésztésre és szaporításra
CA1319634C (en) Vaccine
Rogers et al. Sensitization of guinea pigs to herpes simplex virus

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties